MAPT and Alzheimer disease: studied the development and utilization of protein‐capped nanoparticles to effectively impede tau aggregation in AD.[123] Researchers discovered that the utilization of protein‐capped iron oxide and cadmium sulfide nanoparticles exhibited a significant inhibitory effect on the process of tau polymerization, thereby effectively impeding the aggregation of tau proteins.